bamlanivimab-etesevimab
Due to high frequency of the Omicron variant, bamlanivimab and etesevimab are NOT currently authorized in any U.S. region.
[FormWeb page pending further updates]
Administration Considerations:
Pediatric ED
Main ED/ ED OBS / OB ED
Inpatient (MAIN & HHWC)
Reviewed: March 2021
Updated: September 2021
Due to high frequency of the Omicron variant, bamlanivimab and etesevimab are NOT currently authorized in any U.S. region.
[FormWeb page pending further updates]
Administration Considerations:
Pediatric ED
Main ED/ ED OBS / OB ED
Inpatient (MAIN & HHWC)
Reviewed: March 2021
Updated: September 2021